Chronic Hepatitis C
Chronic hepatitis C steatosis predicts poor response to combination therapy
Published in Hepatitis Weekly, July 10th, 2006
"In this study, we evaluated whether hepatic steatosis affects the viral response to IFN and ribavirin combination therapy in Japanese patients with CHC," wrote R. Yaginuma and colleagues, Juntendo University.
They explained, "Eighty CHC patients treated with IFN alpha-2b and ribavirin for 24 weeks were evaluated retrospectively. Liver biopsy specimens were assessed histopathologically, and grade of steatosis was scored as follows:...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-07-10)
More Articles from Hepatitis Weekly
- Hepatitis B Virus
HBV replication is inhibited by esiRNA more than by synthesized siRNAs - Hepatitis B Virus
Hepatitis B virus propagation requires fibronectin - Hepatitis C Virus
Early steps of hepatitis C virus early infection characterized - Hepatitis C Virus
Hepatitis C virus NS2 and NS3 proteins form a complex - Hepatitis C Virus
Hepatitis C virus recombinant multiepitope protein functions diagnostically - Adverse Drug Reaction
Cancer patients can develop enterocolitis after antibody blockade - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
